A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.
about
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.A Comprehensive Analysis of Plasmodium Circumsporozoite Protein Binding to Hepatocytes.Recent advances in recombinant protein-based malaria vaccines.Particle-based platforms for malaria vaccines.Large screen approaches to identify novel malaria vaccine candidates.Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking VaccinesRhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomesThe stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines.CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay.Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.RTS,S Malaria Vaccine and Increased Mortality in Girls.Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro.Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli
P2860
Q36024455-75FD0AC8-BCB4-44D8-A666-DBB5F04A8B11Q36112823-0DDE1563-DBD8-482B-8463-37CC822CC7D1Q36394182-152F44F5-5F2E-4F72-A0C5-A9D47A169AD5Q36396040-19A42E7D-5E32-408D-8763-694A80E009A0Q36510147-AADC9399-C455-41E6-9999-04E2E0978023Q37402846-B528A006-A6FF-482D-A0BF-3332BF3AD5ECQ37587612-D0F86B7F-E349-48EC-9C1E-B856D87FD770Q37611985-65EB0AD0-1918-4383-AF18-50E0647420CCQ37696415-27610BF2-DF3A-4327-B151-2630F51465A8Q39013988-199D2B69-CF06-4E62-94DB-FE3CBBE267ABQ40270575-12AA35C8-5711-4D39-8084-E4F97DFF748DQ41722577-65033BE0-D482-4B73-9DA8-0EDA0FF78067Q42848608-19923297-7D9A-4ABB-80D9-89C25663B549Q55374996-3784098B-7C9C-4E62-84CD-5FBD100EA70BQ58358482-49E6641F-EB93-4BE9-8BE4-7F9EAEA2DF72
P2860
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@ast
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@en
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@nl
type
label
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@ast
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@en
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@nl
prefLabel
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@ast
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@en
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@nl
P2093
P2860
P50
P1433
P1476
A full-length Plasmodium falci ...... s a malaria vaccine candidate.
@en
P2093
Brian Roberts
Christopher B Fox
Diane M Retallack
Diego Espinosa
Fidel Zavala
Hongfan Jin
Jeffrey R Allen
John Sacci
Jordana G A Coelho-Dos-Reis
P2860
P304
P356
10.1371/JOURNAL.PONE.0107764
P407
P577
2014-09-23T00:00:00Z